longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Clinuvel Pharmaceuticals

CUVL

5.9301.33% ( -0.080 )
Trading: Sep 9, 12:42:24 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 13.22, below the reasonable range, cheaper than 94.59% of the time in the past 1 years, and the industry ranks 31/601, the industry Median -2.59.

13.22xP/E
$6.01Stock price
$0.45Earnings per share
13.22xP/E
Stock price$6.01Earnings per share$0.45

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
16.24x
Typical range
14.34x–16.62x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
018365472

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GRFSUSGRIFOLS SA
10.16x42.44%$5.33B
ACADUSAcadia Pharma
12.49x73.68%$4.75B
PURRUSHyperliquid Strategies
9.21x93.61%$2.36B
AUPHUSAurinia Pharma
6.81x54.40%$2.14B
ADMAUSAdma Biologics
12.65x35.42%$2.14B
LKFTUSLakefront Biotherapeutics
2.60x115.23%$1.80B
VORUSVor BioPharma
2.37x89.77%$1.48B
ABUSUSArbutus Pharma
6.67x533.09%$1.02B
RIGLUSRigel Pharma
2.75x83.91%$884.87M
BVNRYUSBavarian Nordic A/S
3.41x--$818.08M
IRWDUSIronwood Pharma
5.31x715.55%$689.05M
QTTBUSQ32 Bio
10.30x161.36%$348.01M
AGENUSAgenus
3.64x--$334.50M
CUVLUSClinuvel Pharmaceuticals
13.22x--$303.07M
CGENUSCompugen
6.89x173.68%$242.49M
PLXUSProtalix Biotherap
11.27x337.50%$213.51M
VXRTUSVaxart
3.17x328.57%$122.32M
FBIOUSFortress Biotech
0.87x3,742.86%$90.38M
RLYBUSRallybio
1.94x131.45%$88.21M
SPROUSSpero Therap
9.39x293.33%$69.30M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.